People's Republic
Mongolian People’s Republic
... the people remained, in reality, in no one‟s hands‟ On June 30, 1940, a second constitution of Mongolian People‟s Republic was adopted by which the communist regime narrowed down the ...
6
Shared decision-making in the People’s Republic of China: current status and future directions
... People’s Republic of China, geographically focused health services and survey research may help determine how best and to what extent patients and clinicians can and will take part in SDM across different health ...
13
Seroprevalence of Toxoplasma gondii infection among patients with hand, foot and mouth disease in Henan, China: a hospital-based study
... According to the guidelines of the National Health and Family Planning Commission (NHFPC) of the People’s Republic of China for diagnosis and treatment of HFMD (2010 edition, http://www.nhfpc.gov.cn/), HFMD cases ...
5
Prevalence of driver mutations in non-small-cell lung cancers in the People’s Republic of China
... the leading cause of cancer-related death in the People’s Republic of China. Mortality from this cancer was 45.57 per 100,000 of the national population, being 61.00 for 100,000 males and 29.77 for 100,000 ...
9
Rare diseases in China: analysis of 2014–2015 hospitalization summary reports for 281 rare diseases from 96 tertiary hospitals
... People’s Republic of China that was meant to improve ICD coding and funding reimbursement of therapies, experts from the Beijing Society of Rare Diseases for epidemiologic surveil- lance, the book entitled ...
8
The way to early childhood education equity - policies to tackle the urban-rural disparities in China
... the People ’ s Republic of China ...to s rural areas, to solve the issue of kindergarten crunch and to promote the spread of ECE in rural ...People’s Republic of China ...People’s ...
23
Periodic solutions for nonautonomous second order Hamiltonian systems with sublinear nonlinearity
... Department of Mathematics, Nanjing University of Information Science and Technology, Nanjing 210044, Jiangsu, People ’ s Republic of China 2 Jiangsu Key Laboratory for NSLSCS, School of [r] ...
14
Determinants and influencing mechanism of outpatient satisfaction: a survey on tertiary hospitals in the People’s Republic of China
... People’s Republic of China should encourage doctors to pay more attention to the medical needs of outpatients, improve service attitudes, and further increase diagnosis and treatment ...
12
Quality of life assessment in patients with alopecia areata and androgenetic alopecia in the People’s Republic of China
... Given that alopecia areata (AA) and androgenetic alopecia (AGA) are the main types of hair loss in People’s Republic of China, the purpose of this study was to assess the QoL of patie[r] ...
5
Review of the rational use and adverse reactions to human serum albumin in the People’s Republic of China
... People’s Republic of China is low; standards for treatment are considered lower than 25 g/L, which not only increases the number of people treated with HSA, but also offers no consideration for the primary ...
6
Health economic evaluations of medical devices in the People's Republic of China: A systematic literature review
... People’s Republic of China needs to change, to determine which of these, eg, are cost-effective so that the rural areas could also consider which of these products may be accessible for ...
10
Practical use of sevelamer in chronic kidney disease patients on dialysis in People’s Republic of China
... People’s Republic of China were mild-to-moderate GI disorders, such as constipa- tion, flatulence, abdominal distension, dyspepsia, vomiting, nausea, etc, the most commonly observed was constipa- ...
8
Strategies for changing negative public attitudes toward organ donation in the People's Republic of China
... These findings suggest that the existing social education and advertisements for living organ donation are inadequate, which emphasizes the importance of enhancing publicity and education efforts. Consequently, publicity ...
6
A third-party investigation of inpatient satisfaction with a tertiary hospital in People’s Republic of China
... Background: Conflicts between doctors and patients occur in People’s Republic of China each year. Serious negative relationships between doctors and patients are a significant social problem. This study aims to ...
11
Frequency of tuberculosis among diabetic patients in the People's Republic of China
... screening in patients with DM may increase earlier detec- tion, facilitating better treatment of TB. It also may improve clinical outcomes with anti-TB treatment and DM routine care. Moreover, early diagnosis of TB in DM ...
5
Cesarean section in the People’s Republic of China: current perspectives
... People’s Republic of China in the past decades, irrespective of where people lived or their socioeconomic ...People’s Republic of ...People’s Republic of China’s health development approach – ...
16
Systematic review of the prevalence and incidence of Parkinson’s disease in the People’s Republic of China
... the prevalence of PD in the People’s Republic of China has been underestimated. It has been generally acknowledged that the prevalence of PD in Asia, Africa, and South America is significantly lower than that in ...
6
Epidemiology and management of osteoporosis in the People’s Republic of China: current perspectives
... People’s Republic of China, which has the largest population and an increasing proportion of elderly people, as osteoporosis has become a serious challenge to the Chinese government, society, and ...
17
Minimally invasive esophagectomy for esophageal cancer in the People's Republic of China: an overview
... People’s Republic of China now that Chinese cardiothoracic surgeons are receiving adequate training in major ...People’s Republic of China, as confirmed by the increasing number of recently published papers ...
6
<p>Safety and efficacy of combination therapy with apatinib and doxorubicin in metastatic soft tissue sarcomas: an observational study from multiple institutions</p>
... in People ’ s Republic of China and Rivoceranib worldwide) is a broad-spectrum VEGFR TKI that was approved in People ’ s Republic of China in 2014 for the treatment of advanced ...
8